Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 5,203,000 | 4,891,000 | 2,228,000 | 4,601,000 | 4,471,000 |
| Cost of Goods | 1,670,000 | 1,570,000 | 693,000 | 1,478,000 | 1,408,000 |
| Gross Profit | 3,533,000 | 3,321,000 | 1,535,000 | 3,123,000 | 3,063,000 |
| Operating Expenses | 2,430,000 | 2,267,000 | 1,827,000 | 2,253,000 | 2,211,000 |
| Operating Income | 1,103,000 | 1,054,000 | -292,000 | 870,000 | 852,000 |
| Other Income | 118,000 | 153,000 | -278,000 | 386,000 | 133,000 |
| Pre-tax Income | 1,221,000 | 1,207,000 | -570,000 | 1,256,000 | 985,000 |
| Income Tax | 258,000 | 330,000 | -92,000 | 292,000 | 203,000 |
| Net Income Continuous | 963,000 | 647,000 | 68,000 | 753,000 | 588,000 |
| Net Income Discontinuous | 42,000 | 14,000 | 606,000 | 105,000 | 118,000 |
| Minority Interests | 241,000 | N/A | N/A | N/A | N/A |
| Net Income | $764,000 | $661,000 | $-89,000 | $858,000 | $706,000 |
| EPS Basic Total Ops | 0.38 | 0.33 | -0.05 | 0.43 | 0.36 |
| EPS Basic Continuous Ops | 0.36 | 0.32 | -0.36 | 0.38 | 0.30 |
| EPS Basic Discontinuous Ops | 0.02 | 0.01 | 0.31 | 0.05 | 0.06 |
| EPS Diluted Total Ops | 0.38 | 0.33 | -0.05 | 0.43 | 0.36 |
| EPS Diluted Continuous Ops | 0.36 | 0.32 | -0.36 | 0.38 | 0.30 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.01 | 0.31 | 0.05 | 0.06 |
| EBITDA(a) | $1,306,000 | $1,305,000 | $-38,000 | $1,083,000 | $1,061,000 |